Osteoporosis in Older Adults.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32773051.
- Also identified by DOI 10.1016/j.mcna.2020.06.004.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Osteoporosis and osteoporosis-related fractures are common causes of morbidity and mortality in older adults. Healthy adults should be counseled about measures to prevent osteoporosis. Women should be screened for osteoporosis beginning at age 65. Screening for osteoporosis in men should be considered when risk factors are present. Appropriate screening intervals are controversial. Women and men with osteoporosis should be offered pharmacologic therapy. Choice of therapy should be based on safety, cost, convenience, and other patient-related factors. Bisphosphonates are a first-line therapy for many patients with osteoporosis. Other treatments for osteoporosis include denosumab, teriparatide, abaloparatide, romosozumab, and selective estrogen receptor modulators.
Medical subject headings
- Bone Density Conservation Agents
- Osteoporosis
- Osteoporosis, Postmenopausal
- Osteoporotic Fractures